fda tirzepatide update today says the weight-loss drug shortage is over FDA approval for Zepbound (tirzepatide)

"Long-term neurodevelopmental outcome in conservatively treated congenital hyperinsulinism"

Every protocol is individualized

"I couldn't renew my prescription." Cox says the pharmacist suggested calling a few times a week to see if the drug was back in stock

Weeks 24 as doses increase to 0.5 mg: Fasting blood sugar frequently drops 1525 mg/dL as insulin sensitivity improves and hepatic glucose output decreases

Biochemical and omics biomarkers in cognition Classical CSF and plasma biomarkers A40 / A42 (important ratio in amyloid pathology) Total tau / p-tau181 / p-tau217 (tauopathic markers) Neurofilament light (NfL) : axonal degeneration marker GFAP : astrocytic activation BDNF and pro-BDNF : neurotrophic activity IL-6, TNF, IL-1 : neuroinflammation Transcriptomics and epigenomics Hippocampal RNA-seq after chronic administration of Semax or Selank often reveals a neurotrophic activation signature (BDNF, NT3, NGF, NR4A1-3) coupled with anti-inflammatory modulation (NF-B targets down)